Timothy W. Kinlock

Friends Research Institute — United States

Medicine · Health Sciences

32h-index3.4kcitations94works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Substance Abuse Treatment and Outcomes(69), Opioid Use Disorder Treatment(38), Prenatal Substance Exposure Effects(29), Criminal Justice and Corrections Analysis(21), Crime Patterns and Interventions(15)

Publications94 total

TWELVE. SELF-HELP INITIATIVES TO REDUCE THE RISK OF RELAPSE
Yale University Press eBooks·2017
Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder
Addiction·2017· 52 citedOpen Access
A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release
Drug and Alcohol Dependence·2017· 67 cited
Factors Associated With Receiving Rapid HIV Testing Among Individuals on Probation or Parole
Journal of Correctional Health Care·2016· 6 citedOpen Access
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders
New England Journal of Medicine·2016· 310 citedOpen Access
Extended-release naltrexone for opioid relapse prevention among opioid-dependent, criminal justice-involved adults
Drug and Alcohol Dependence·2015· 8 cited
Patient selection for extended-release naltrexone among criminal justice-involved persons with opioid use disorder
Drug and Alcohol Dependence·2015· 3 cited
Heroin and Other Opiates
2015· 1 cited
Buprenorphine dose induction in non-opioid-tolerant pre-release prisoners
Drug and Alcohol Dependence·2015· 21 citedOpen Access
A Phase 4, Pilot, Open-Label Study of VIVITROL® (Extended-Release Naltrexone XR-NTX) for Prisoners
Journal of Substance Abuse Treatment·2015· 49 cited
Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: Rationale and design of a randomized controlled effectiveness trial
Contemporary Clinical Trials·2015· 29 citedOpen Access
Depot naltrexone as relapse prevention for opioid-dependent parolees
Drug and Alcohol Dependence·2014· 7 cited
OR14-4 * EFFECTIVENESS OF EXTENDED-RELEASE NALTREXONE (XR-NTX) AMONG CRIMINAL JUSTICE-INVOLVED PERSONS WITH OPIOID USE DISORDERS
Alcohol and Alcoholism·2014· 3 citedOpen Access
Severity, frequency and variety of crime in heroin-dependent prisoners enrolled in a buprenorphine study
Drug and Alcohol Dependence·2014
A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry
Drug and Alcohol Dependence·2014· 108 citedOpen Access
Buprenorphine Treatment for Probationers and Parolees
Substance Abuse·2014· 20 citedOpen Access
A cluster randomized trial of an organizational linkage intervention for offenders with substance use disorders: study protocol
Health & Justice·2013· 25 citedOpen Access
Individual Patient and Program Factors Related to Prison and Community Treatment Completion in Prison-Initiated Methadone Maintenance Treatment
Journal of Offender Rehabilitation·2013· 10 citedOpen Access
The Severity, Frequency, and Variety of Crime in Heroin-Dependent Prisoners Enrolled in a Buprenorphine Clinical Trial
The Prison Journal·2013· 3 citedOpen Access
Gender Differences among Prisoners with Pre-Incarceration Heroin Dependence Participating in a Randomized Clinical Trial of Buprenorphine Treatment
Journal of Offender Rehabilitation·2013· 10 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Michael Gordon(28), Robert P. Schwartz(18), David N. Nurco(17), Kevin E. O’Grady(16), Thomas E. Hanlon(13), Terrence T. Fitzgerald(7), Robert J. Battjes(7), Peter D. Friedmann(6), Monique E. Wilson(5), Frank J. Vocci(5), Karen Rose Duszynski(5), John W. Shaffer(5), Joshua D. Lee(4), Edward V. Nunes(4), Tamara Y. Boney(4), Charles P. O’Brien(4), John C. Ball(4), Randall Hoskinson(3), Donna T. Chen(3), Richard J. Bonnie(3)